Skip to main content
Molecular Neurodegeneration logoLink to Molecular Neurodegeneration
. 2024 Dec 18;19:94. doi: 10.1186/s13024-024-00791-z

Correction: The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons

Jace Jones-Tabah 1,2, Kathy He 1, Nathan Karpilovsky 1, Konstantin Senkevich 1,2, Ghislaine Deyab 1, Isabella Pietrantonio 1, Thomas Goiran 1, Yuting Cousineau 2, Daria Nikanorova 4, Taylor Goldsmith 3, Esther del Cid Pellitero 1, Carol X-Q Chen 3, Wen Luo 3, Zhipeng You 3, Narges Abdian 3, Jamil Ahmad 1,2, Jennifer A Ruskey 1,2, Farnaz Asayesh 1,5, Dan Spiegelman 1, Stanley Fahn 6, Cheryl Waters 6, Oury Monchi 2,7,8, Yves Dauvilliers 9, Nicolas Dupré 10,11, Irina Miliukhina 12, Alla Timofeeva 13, Anton Emelyanov 13, Sofya Pchelina 13, Lior Greenbaum 14, Sharon Hassin-Baer 14,15,16, Roy N Alcalay 6,17, Austen Milnerwood 2, Thomas M Durcan 3, Ziv Gan-Or 1,5, Edward A Fon 1,2,
PMCID: PMC11657430  PMID: 39696367

Correction : Mol Neurodegeneration 19, 88 (2024)

https://doi.org/10.1186/s13024-024-00779-9

The authors wish to note the Grant ID, MFFF – 007905 relating to the mentioned grants to ZGO and EAF from the Michael J. Fox Foundation which was mistakenly omitted from the original article [1].

The authors also wish to note that Lior Greenbaum is only affiliated to affiliation #14 (Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel).

Reference

  • 1.Jones-Tabah J, He K, Karpilovsky N, et al. The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons. Mol Neurodegeneration. 2024;19:88. 10.1186/s13024-024-00779-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecular Neurodegeneration are provided here courtesy of BMC

RESOURCES